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Peroneal artery-only runoff following endovascular
revascularizations is effective for limb salvage in
patients with tissue loss
Hasan H. Dosluoglu, MD,a,b Gregory S. Cherr, MD,a,c Purandath Lall, MBBS,a,b
Linda M. Harris, MD,b and Maciej L. Dryjski, MD,b Buffalo, NY
Objective: Peroneal artery bypass is effective for limb salvage (LS), however, the efficacy of peroneal artery-only runoff
(PAOR) following endovascular (EV) interventions is unknown. The goal of our article was to compare the efficacy of EV
interventions with PAOR to those with other runoff vessels for LS in patients presenting with tissue loss.
Methods: A retrospective review of 111 consecutive patients who underwent infrainguinal EV revascularizations for
nonhealing ulcers/gangrene between June 2001 and December 2006 was performed. Patients with PAOR (n 33) were
compared with those with other vessel runoff (OTHER, n  78). Fisher exact test and 2 test were used for comparing
variables, Kaplan-Meier analyses for patency, LS, and Cox regressionmultivariate analysis was used for identifying factors
associated with limb loss.
Results: The patients in PAOR were older, but other morbidities were similar between groups. The most distal level of
intervention was infrapopliteal (tibioperoneal or peroneal artery) in 42% in PAOR group whereas this was 24% in
OTHER group (P .071). Preoperative ankle-brachial index (ABI) was similar (0.49  0.23 vs 0.50 0.23), however,
postprocedure ABI was significantly less for patients with PAOR (0.76  0.21 vs 0.92  0.13, P  .001). The primary
patency, assisted primary patency, secondary patency and LS were not significantly different between groups. There was
also no difference in time-to healing between groups (PAOR vs OTHER, 2.9  2.1 mo vs 3.7  3.6 mo, P  .319). We
found the presence of gangrene (odds ratio [OR]: 3.5, 95% confidence interval [CI], 1.1-10.8, P  .028) and
dialysis-dependence (OR: 2.9, 95% CI, 1.0-8.2, P  .046) to be associated with limb loss, when adjusted for diabetes,
hypertension, hyperlipidemia, smoking, location of wound, and PAOR.
Conclusion: Endovascular revascularization with PAOR results in acceptable patency and limb salvage rates in patients
presenting with tissue loss, and is equivalent to other vessel runoff for patency, limb salvage and wound healing rates.
(J Vasc Surg 2008;48:137-43.)The peroneal artery has been reported to be relatively
spared from terminal stages of atherosclerosis in anatomy
dissections.1 It has multiple collaterals and supplies the
pedal arteries via anterior and posterior branches. It was
found to be the least diseased runoff vessel in 40% of
patients and was the only runoff vessel in 37% of 289
angiographic studies performed by Karmody et al.2
Although initial reports on peroneal artery bypasses
were not favorable,3,4 it has since been well established that
bypass to the peroneal artery provides comparable hemo-
dynamic improvement and limb salvage to other infra-
genicular bypasses, with themost significant determinant of
success being the quality of the vein.5-7 However, the role
of peroneal bypass in patients with extensive infection or
tissue loss at the forefoot is still debatable.2
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doi:10.1016/j.jvs.2008.02.070The runoff status has been reported to affect patency
following endovascular interventions on the femoropopli-
teal segment.8,9 However, the results of isolated peroneal
artery runoff have not been studied, and only a few small
series report on balloon angioplasties on tibioperoneal and
infrageniculate segments.10,11 Faglia et al12 recently sug-
gested that in some patients with diabetes and critical limb
ischemia, the recanalization of the peroneal artery alone
may not be sufficient to avoid amajor amputation. The goal
of our retrospective study was to compare the efficacy of
endovascular interventions with peroneal artery-only run-
off with those with other runoff vessels for limb salvage
(LS) in patients presenting with tissue loss (ischemic ulcer
or gangrene).
MATERIAL AND METHODS
Design. All consecutive patients who presented to the
Veterans’ Administration Western New York Healthcare
System between June 1, 2001 and December 31, 2006
with tissue loss (Rutherford category 5-6)13 who under-
went a technically successful infrainguinal revascularization
either by endovascular, or open bypass procedures in whom
at least one vessel runoff was achieved were identified from
our prospectively maintained database. Patients who un-
derwent endovascular interventions comprised our study
population. Patients were categorized into those with per-
oneal artery-only runoff (PAOR) or those with at least one
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procedure (OTHER).
Methodology. The patients’ demographics, comor-
bidities, clinical presentation, preoperative functional sta-
tus, noninvasive arterial studies, other imaging studies,
details of the procedures performed, the most distal level of
intervention, postoperative course, length of stay (LOS),
follow-up arterial studies, and status of their limbs on last
follow-up were recorded. TransAtlantic Society Consensus
(TASC) classification14 of the treated lesions were prospec-
tively entered into our database. The database was not revised
after the TASC II recommendations were published,15 as
publication of the updated reporting standards coincidedwith
the end of the study period, and the newer document did not
classify infrapopliteal lesions.
All endovascular procedures were performed by vascu-
lar surgeons (99% by the first author) in the operating room
using the OEC 9800 system (General Electric Medical
Systems, Salt Lake City, Utah). An increasingly aggressive
endovascular-first approach was adopted for all patients
with critical limb ischemia starting from 2002, and the
decision to proceed with endovascular intervention or open
bypass was made by the vascular surgeon, with increasing
complex interventions over the study period. Most infrain-
guinal interventions were performed via contralateral fem-
oral artery approach using 6F sheath. TASCA and B lesions
at the femoropopliteal artery levels were attempted to be
treated using percutaneous transluminal angioplasty
(PTA), and stents were used for flow-limiting dissections,
or residual stenosis or recoil of 30%. Most occlusions
were crossed using a combination of Glidewire (Terumo,
Somerset, NJ) and Glidecath (4 or 5F, Terumo). Intralu-
minal crossing was intended for all cases. An intravascular
ultrasound guided reentry device (Pioneer catheter,
Medtronic, Santa Rosa, Calif) was used in five cases, one of
which was at the infrapopliteal level. Stent placement was
performed after predilation in all TASC C and D superficial
femoral artery (SFA) lesions. Balloon angioplasty with pro-
visional stenting was used for popliteal and infrapopliteal
stenoses and occlusions. Debulking procedures as an ad-
junct were used in a small number of patients (Excimer laser
atherectomy, Spectranetics Corp, Colorado Springs, Colo,
11 patients; SilverHawk atherectomy, Foxhollow Inc, Red-
wood City, Calif, three patients).
Patients typically received 5000 U heparin after sheath
placement, and the heparin was not reversed at the end of
the procedure. Sheaths were removed using manual com-
pression in the recovery room after activated clotting time
was180 seconds before 2004. Closure devices (ProGlide
or Starclose, Perclose, Abbott Vascular Inc, Redwood City,
Calif) were deployed at completion of the procedure begin-
ning in 2005. Clopidogrel bisulfate 75 mg was started
before the planned procedure or was started in recovery
room (300 mg). All patients were kept on clopidogrel 75
mg and enteric coated acetyl salicylic acid (ECASA) 81 mg
for a minimum of 30 days followed by lifelong ECASA.
All patients were followed by clinical assessment and by
our vascular laboratory during the first postoperative visit(1-4 weeks), and at 3, 6 months, and every 6 months
thereafter for ankle-brachial index (ABI) measurements,
graft or stent velocities, and duplex imaging. All patients
with open wounds were followed in our vascular surgery
wound clinic until wounds were all healed. The wound
status (unchanged or worse, healing or healed) and time to
complete healing was recorded. Healing wound was de-
fined as a wound with clean base with healthy granulation
tissue, decreasing in size. Skin perfusion pressure or trans-
cutaneous oxygen pressures were unavailable and were
therefore not measured in these patients. Angiography was
performed when noninvasive studies suggested restenosis
or occlusion, or when adequacy of the patency or adequacy
of foot perfusion was in question due to suboptimal duplex
imaging or nonhealing of the wound. Restenosis was de-
fined as 50% decrease in luminal diameter seen on non-
invasive imaging or angiography. Reinterventions were
performed for maintaining patency or when clinically indi-
cated (nonhealing wound, recurrent ulcer or pain). Society
for Vascular Surgery (SVS) reporting standards for lower
extremity arterial procedures were followed.13
Definitions. Ischemic tissue loss was defined as the
presence of nonhealing ulcer or gangrene in the presence of
objective evidence of arterial occlusive disease (resting an-
kle pressure 60mmHg, or flat or barely pulsatile ankle or
transmetarsal pulse volume recordings).13 A patent runoff
vessel was defined as an infrapopliteal vessel without a
hemodynamically significant (50%) angiographic stenosis
distal to the treated site,13 and the number of adequately
patent runoff vessels (0-3) was calculated after all interven-
tions were completed for that limb. Technical success was
defined as a patent vessel with 30% residual stenosis
following the intervention.
Coronary artery disease was defined as documented
angina pectoris, myocardial infarction (MI), congestive
heart failure, or history of coronary artery revascularization.
Renal insufficiency was defined as a serum creatinine higher
than 1.5 mg/dL. Cerebrovascular disease (CVD) was de-
fined as a history of stroke, transient ischemic attack, ca-
rotid artery revascularization, or a known 50% carotid
artery stenosis. Hypertension was defined as a previous
documentation of systolic blood pressure of150mmHg,
or diastolic blood pressure of90mmHg, and being on at
least onemedication for blood pressure control. Hypercho-
lesterolemia was defined as fasting cholesterol level  200
mg/dL, a low density lipoprotein level  130 mg/dL, or
triglycerides 200 mg/dL. Diabetes mellitus (DM) was
defined as fasting plasma glucose  110 mg/dL or a
hemoglobin A1c 7%.
Statistical analysis. Data analysis was performed us-
ing SPSS 14.0 software (SPSS Inc, Chicago, Ill). Kaplan-
Meier analysis and log rank test were used to compare
groups for primary patency (PP), assisted-primary patency
(APP), secondary patency (SP), limb salvage (LS), and
overall survival on an intent-to-treat basis. Amputation-free
survival was also calculated using Kaplan-Meier analysis
with log rank test, in which both amputation and death
were considered as endpoints. Demographic comparisons
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variables, and by t test for continuous variables. Univariate
analyses were performed for identifying factors predicting
limb loss, and multivariate analysis was performed using
Cox proportional regression to identify the independent
predictors of limb loss. All P values were considered signif-
icant if 0.05. Institutional Review Board approval was
obtained for the study.
RESULTS
A total of 143 patients (170 limbs) with ischemic tissue
loss were treated by either by bypass (59 limbs) or endo-
vascular revascularizations (111 limbs) in whom at least one
vessel runoff to the foot was achieved. During this period,
an additional eight patients with tissue loss had infraingui-
nal endovascular attempts in which in-line flow to the foot
could not be achieved (primary success rate, 95.5%).
In the endovascular treated group, there were 33 limbs
in the PAOR group, and 78 limbs in the OTHER group.
During the same time period, 59 patients with ischemic
tissue loss had infrainguinal open bypass procedures, and
15 had peroneal artery-only runoff (PAOR-OPEN), and
44 had other than peroneal-only runoff (OTHER-OPEN).
Patients in the PAOR group were older (77.3 10.3 vs
71.7 8.9, P .005), but there were no other differences
in comorbidities or clinical presentation (Table I). The
procedures performed are summarized in Table II. There
was no statistically significant difference between the most
distal level of interventions between two groups (infrapop-
liteal interventions, 42% vs 24%, PAOR vs OTHER, P 
.071). The TASC classification of the worst-treated arterial
segments were similar between groups (TASC A: 12%; B:
3%; C: 27%; D: 58% in PAOR, and 6%; 9%; 36%; and 49% in
OTHER, P  .859). In the PAOR group, 21 patients had
SFA/popliteal stenting (Smart, Cordis, Johnson and John-
son, Miami, Fla) with a mean stented length of 17.2 9.6
cm, ranging from 4 to 35 cm (2.3  1.0 stents per SFA),
Table I. Age, comorbidities, and presentation mode of
endovascular treated patients with peroneal artery-only




(n  78) P value
Age 77.3  10.3 71.7  8.9 .005
CAD 61% 64% .830
HTN 67% 69% .825
DM 76% 71% .649
CVD 27% 22% .625
Renal insufficiency 30% 29% 1.0
Dialysis-dependence 12% 10% .748
COPD 27% 23% .636
Hyperlipidemia 58% 65% .520
Gangrene 52% 60% .409
PAOR, Peroneal artery-only runoff; CAD, coronary artery disease; HTN,
hypertension; CVD, cerebrovascular disease; COPD, chronic pulmonary
occlusive disease; DM, diabetes mellitus.three patients had PTA alone, 13 patients had infrapoplitealPTA (three with adjunctive use of Excimer laser atherec-
tomy), and one patient had infrapopliteal stent (Cypher,
Cordis, Johnson and Johnson, Miami, Fla) after significant
recoil following PTA. In the OTHER group, 61 patients
had SFA/popliteal stenting (Smart) with a mean stented
length of 21.6 10.1 cm, ranging from 6 to 40 cm (2.7
1.3 stents per SFA), five patients had PTA alone, 17 pa-
tients had infrapopliteal PTA (five with adjunctive use of
Excimer laser atherectomy and three with SilverHawk
atherectomy), and two had infrapopliteal stent placement
(one Cypher, one Precise, Johnson and Johnson, Miami,
Fla) after unsuccessful PTA.
The ABI was measured before and after intervention in
all patients. Peroneal artery signal was not used for calcu-
lating the ABI measurements. The tibial vessels were non-
compressible in 26% of patients. For all others, the ABI
increased from 0.49  0.23 to 0.76  0.21 in PAOR, and
from 0.50  0.23 to 0.92  0.13 in the OTHER group.
The postoperative ABI was significantly higher in the
OTHER group than PAOR group (P  .001). Inciden-
tally, the postoperative ABI was similar in those who even-
tually underwent a major amputation to those who did not
(0.87  0.23 vs 0.88  0.16, P  .840).
The postprocedural length-of-stay (LOS) was 5.5 
8.8 days, and was not different between groups (6.8 13.2
days for PAOR vs 4.9  6.0 days for OTHER, P  .304).
There was no 30-day mortality in PAOR group, whereas it
was 2.6% in the OTHER group. In the PAOR group, one
patient (3.3%) had an early stent occlusion (SFA) and one
(3.3%) underwent exploration for bleeding. In the
OTHER group, one patient had a nonfatal MI (1.2%), and
two patients developed pseudoaneurysms at the puncture
site.
On last follow-up, 61% of patients in the PAOR had
completely healed wounds, 21% had non-intact skin with
healing wounds, and 18% had a major amputation. Six of
the seven patients in this group who did not achieve full
wound healing died within 3 months of the intervention
either at home or rehabilitation center, and all had healing
wounds as documented in their follow-up wound clinic
notes. The seventh patient had healed his wound 3 months






SFA PTA/stenting 19 (58%) 59 (76%)
with iliac 1 (3%) 8 (10%)
Excimer 3 (4%)
Infrapopliteal 14 (42%) 19 (24%)
with iliac 1 (1%)
with SFA stenting 5 (15%) 7 (9%)
Excimer 3 (9%) 5 (6%)
SilverHawk 3 (4%)
PTA, Percutaneous transluminal angioplasty; SFA, superficial femoral ar-
tery.after the initial interventions but returned with recurrent
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reintervention with a healing wound. Sixty-four percent of
the OTHER group had completely healed wounds, 18%
had healing wounds, and 18% had a major amputation,
with no difference between the groups. Seven of the 14
patients in this group died within 3 months of the interven-
tion with improved wounds due to unrelated causes either
at home or rehabilitation centers. Four additional patients
died at 4, 7, 10, and 13 months in nursing homes, all with
clean, improved wounds. One nonambulatory patient is
alive at 24 months with a clean, stable pressure wound.
Two patients had recurrence of their wounds after initial
healing, one of whom died with healing wound, and the
other has healing wounds after reintervention at 34
months. There was also no difference in time-to-healing
between groups (PAOR vs OTHER, 2.9  2.1 months vs
3.7 3.6 months, P .319). The 24-month amputation-
free survival was also similar between groups (PAOR vs
OTHER, 57%  9% vs 52%  6%, P  .734), which was
more of a reflection of the poor overall survival of both
groups (24 month survival, 62% 9% vs 61% 6%, PAOR
vs OTHER).
There were six major amputations in the PAOR group
(18%) and 14 in theOTHER group (18%). All amputations
occurred despite a patent EV-treated arterial segment in the
PAOR group, three within 30 days, two between 1 and 3
months, and one at 8 months. All were related to extensive
tissue loss secondary to the primary infection, or recurrent
infection, and all were diabetics. In the OTHER group, 2
occurred within 30 days, 3 occurred between 1 and 3
months, 5 between 3 and 12 months, and 4 after 12
months. Nine were related to early (2 patients) or late (7
patients) infections, three were due to reocclusions, and
two were due to inability to reverse the extensive ischemic
damage. Eleven of the 14 amputations in the OTHER
group occurred despite patent endovascular-treated arter-
ies, and 12 of the 14 patients were diabetics. In the PAOR
group, the 24-month LS rate for patients withDMwas 75%
 9%, while it was 100% in patients without DM (P 
.159). In the OTHER group, the 24-month LS rate was
76% 7% in patients with DM, whereas it was 95% 5% in
patients without DM (P  .106). The LS rate in patients
with DM was similar between PAOR and OTHER groups
(75%  9% vs 76%  7%, P  .814).
The mean follow-up was 19.2  13.4 months. In the
PAOR group, three patients had SFA reocclusions, without
subsequent limb loss (two patients underwent bypass pro-
cedures, and one was asymptomatic with healed wounds
and was not treated). Additional eight patients had reinter-
ventions for loss of hemodynamic patency (in-stent reste-
nosis in five patients, new stenosis in runoff vessels in three
patients). Two of these patients had asymptomatic 80%
restenosis, and the remaining six had recurrent ulcers or
refractory wound. In the OTHER group, five patients
presented with occlusions; one had nondisabling claudica-
tion with healed wounds and remained untreated. The
other four patients underwent thrombolysis, one of whom
underwent BKA; two patients’ reconstructions remainedpatent after additional PTA/stenting, and one patient’s
artery reoccluded 10 months later with intact skin, and no
symptoms. An additional 10 patients had reinterventions
for restenosis (seven patients), or new stenosis in runoff or
inflow vessels due to loss of hemodynamic patency (three
patients).
The PP (Fig 1), APP, and LS (Fig 2) rates for PAOR
and OTHER groups are shown on Table III, showing no
statistically significant differences. There was no difference
in 12-month LS and PP when PAOR (n  33) were
compared with EV-treated patients who had one-vessel
(AT or PT) runoff (n  19), or one-vessel runoff (n 
59). The 12-month LS for one-vessel (AT/PT) was 72%
11%, whereas this was 80%  8% in PAOR group
(P .296), and 90% 4% in those withone-vessel runoff
(P .204 vs PAOR-EV). The 12-month PP for PAORwas
73%  9%, whereas this was 74  12% in patients with
1-vessel (AT/PT) runoff (P  .668), and 77%  6% for
those with one-vessel runoff (P  .150).
There were 15 patients who underwent infrainguinal
bypass procedures for tissue loss during the same time
period who had peroneal artery-only runoff (PAOR-
OPEN). The 6-month LS rate was 76%  12% for PAOR-
OPEN, whereas this was 85%  6% for PAOR group
(P .525). Further subgroup analyses were not performed
due to the small number of patients in the PAOR-OPEN
group.
In the whole cohort of 111 limbs treated with endo-
vascular interventions, the LS rate was significantly worse in
patients presenting with gangrene than nonhealing ulcers
(24-month LS 73%  6% vs 96%  4%, P  .012), in
patients with DM (24-month LS in DM, vs non-DM, 76%
Fig 1. Primary patency rates in peroneal artery-only runoff
(PAOR, n  33) and those with other runoff (OTHER, n  78)
(P  .186).
Months 0 6 12 18 24 30 36 42 48
PAOR 33 19 14 9 7 5 3 2 1
OTHER 78 56 40 29 17 10 6 1 15% vs 96%  4%, P  .046), and dialysis-dependence
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 1 Dosluoglu et al 141(12-month LS 65%  14% vs 87%  4%, P  .025).
However, presence of CAD, hyperlipidemia, hypertension,
active smoking, and location of the tissue loss (forefoot vs
hindfoot) was not associated with increased risk for limb
loss. In multivariate analysis using Cox regression, we
found the presence of gangrene (odds ratio [OR]: 3.9, 95%
confidence interval [CI], 1.2-12.0, P .019), and dialysis-
dependence (OR: 2.9, 95% CI, 1.0-8.2, P  .046) to be
associated with limb loss when adjusted for diabetes, hyper-
tension, hyperlipidemia, smoking, location of wound, and
PAOR.
DISCUSSION
Although the indirect arterial blood flow to the foot via
the peroneal artery was previously considered to be insuffi-
cient to heal severely ischemic, gangrenous wounds, the
adequacy of open bypass to the peroneal artery for achiev-
ing wound healing in patients with ischemic tissue loss at
the foot has been established.5-7,16 This was reported to be
independent of angiographic documentation of patent
pedal arteries17 and direct communication of the peroneal
artery with the pedal vessels.18 Attempts at describing
angiographic scoring systems for predicting graft patency
rates have not been successful.4,19,20 The concern among
surgeons that the peroneal artery reconstruction would
result in hemodynamic failure and hence poorer wound
healing has been shown not to be true by Raftery et al7 who
demonstrated that peroneal bypasses achieve hemody-
namic results equivalent to anterior and posterior tibial
bypass grafts.
The efficacy of endovascular interventions in limb sal-
vage has recently been shown to be comparable to open
Fig 2. Limb salvage rates in peroneal artery-only runoff (PAOR ,
n  33) and those with other runoff (OTHER, n  78) (P 
.902).
Months 0 6 12 18 24 30 36 42 48
PAOR 33 21 19 16 14 12 9 4 1
OTHER 78 62 50 37 25 16 10 1 1bypass procedures,21-23 but the adequacy of the peronealartery runoff for achieving limb salvage and wound healing
with endovascular interventions in these patients has not
been investigated. Runoff scores have been reported to be
associated with improved patency rates and outcomes in
these patients by DeRubertis et al,8 who reported that the
12-month primary patency for patients with three-vessel
runoff was 83%  6%, whereas those with three-vessel
runoff achieved 52% 6% PP (P .02). These authors did
not specify the patent vessel in their single-vessel runoff
group. Moreover, the proportion of diabetic patients with
three-vessel runoff in their series was only 17%, which
included patients with claudication and rest pain without
tissue loss. Only 10% of patients in our series and 16% of
patients in the series of Faglia et al12 had three-vessel
runoff, making this finding not widely applicable to the
patients presenting with tissue loss. In addition, this may
also suggest that the poorer patency and limb salvage
rates in those withthree-vessel runoff may be more due
to an overall increased atherosclerotic burden, than the
runoff itself. Further studies are needed to address this
question.
Faglia et al12 recently reported their analysis on factors
associated with limb loss following endovascular interven-
tions in patients with limb-threatening ischemia. They at-
tempted limb salvage in 420 patients and achieved in-line
flow in 396 patients. Of these, 186 of them had single-
vessel runoff, and 104 had the peroneal artery as the runoff
vessel (62 had anterior tibial, 20 had posterior tibial artery).
Supramalleolar amputations were performed in 22 patients,
15 of whom had no in-line flow to the foot, and seven of
these had the peroneal artery as the single runoff. These
authors suggested that peroneal artery may not be adequate
in some patients, however, they did not specify how to
determine which patients would do well and which would
not with peroneal revascularization.
We found that patients with tissue loss with PAOR
following endovascular interventions were an average of 6
years older than those who had other runoff vessels. The
morbidities and presentation (gangrene vs ulcer) were oth-
erwise similar between groups. We found less improvement
in ABI in the PAOR group, however, the PP, APP, SP, and
LS rates were comparable. This suggests that peroneal
artery runoff is an acceptable runoff vessel following endo-
vascular interventions, similar to the findings for open
bypass.
The number of patients who underwent open revascu-
larization with a resultant peroneal artery-only runoff was
small in our series, therefore, we cannot compare the effi-
cacy of PAOR following endovascular interventions with
those with open bypasses. However, the LS rates in our
PAOR group (81% at 24 months) was similar to the previ-
ously reported LS rates following peroneal artery bypass
procedures mostly using saphenous vein grafts (24-month
LS 70%-93%).5-7,16,19,20 The mean time to wound healing
also seems to be comparable to these series ranging be-
tween 12 to 20 weeks.5
All major amputations in the PAOR group occurred in
diabetic patients with gangrene and infection and occurred
; LS, li
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analysis identified gangrene and dialysis-dependence as the
significant predictors of limb loss, whereas DM and pero-
neal artery-only runoff were not. We cannot say that the
peroneal artery-only runoff was more likely to result in a
major amputation, as amputations with other patent runoff
vessels occurred as well. In addition, amputation with
patent revascularization is not unique to the peroneal ar-
tery, and has been reported to occur in 17% of all tibial
revascularizations, likely reflecting aggressive attempts at
limb salvage.24,25 On the other hand, it is impossible to
dismiss the fact that all patients who underwent major
amputations in the PAOR group, and 86% of all amputa-
tions in the OTHER group occurred in patients with DM,
all but one with patent recanalized segments. Therefore, as
suggested by Faglia et al, the adequacy of a reconstruction
with peroneal-only runoff in some diabetic patients with
infected gangrene and major tissue loss following debride-
ment may not be adequate, and more direct blood flow to
the involved angiosome26 may be necessary, either with
additional endovascular recanalizations or direct bypass.
However, since the major determinant of limb loss is the
amount of tissue loss with extensive gangrene and over-
whelming infection, limb loss may still be inevitable even if
normal perfusion is restored in these patients.
We found dialysis-dependence to be the other factor
independently associated with limb loss in our series, and
12-month LS rate was 65% in the 11 patients in our series.
Risk of limb loss in patients with dialysis-dependence has
been reported to be higher following infrainguinal bypass
procedures.27,28 Johnson et al28 reported that having gan-
grene further decreased the 12-month limb salvage rate
from 74% to 51%. It is also interesting to note that limb loss
has been reported to occur despite a patent bypass graft in
40% to 60% of patients in this patient population, which is
similar to our findings.
The choice of the target vessel for open revasculariza-
tion is affected by various factors, including the length and
the quality of the conduit, and the quality of the vessel at
exploration.5,17,29 The presence of active infection near the
distal incision site is also a consideration when determining
the distal target vessel.17 The factors to consider to achieve
good results following endovascular revascularizations are
the runoff score with its significant impact on patency, and
the adequacy of the hemodynamic increase in blood flow
following the intervention for healing wounds, and achiev-
Table III. Primary, assisted primary, secondary patency, a
LS PP
12 mo 24 mo 12 mo
PAOR (n  33) 81%  7% 81%  7% 73%  9%
OTHER (n  78) 86%  4% 82%  5% 77%  5%
P value .902
PP, Primary patency; APP, assisted primary patency; SP, secondary patencying limb salvage. Our results showed that the time tohealing and the condition of the foot in last follow-up were
very similar between PAOR and OTHER groups. In addi-
tion, we did not see any significant differences in patency
rates, suggesting that peroneal artery provided adequate
runoff as the other vessels with endovascular revasculariza-
tion.
Since the perfusion of the foot has been reported to
have segmental distribution, especially in diabetic pa-
tients,26 we prefer to recanalize or treat the infrapopliteal
vessel that directly feeds the part of the foot with tissue loss.
However, this is not always feasible or practical. We do treat
focal lesions in AT or PT vessels in addition to the peroneal
artery in selected cases to improve runoff score and increase
the blood flow to the foot, however, in many of our
patients, the least-diseased, largest-caliber infrageniculate
vessel is the peroneal artery.
The perioperative morbidity andmortality was minimal
in our series due to the minimally invasive nature of the
interventions, however overall mortality was high (24-
month survival 62% in PAOR and 61% in OTHER group),
but was similar to the series of Ingle et al10 (2 year mortality
43%), which also only included patients who underwent
infrapopliteal subintimal angioplasty for limb salvage pur-
poses. Few reports on peroneal artery bypass actually give
survival rates in their patients, and Abou-Zamzam5 re-
ported a 24-month survival of 75% which is 15% above our
observed rates. This possibly is a reflection of case selection
for open bypasses and the increased number of higher risk
patients having interventions for limb salvage in this decade
with less invasive techniques.
The weaknesses of our study include that it is retrospec-
tive in a relatively small number of patients treated by a
single surgeon in a single-center in a nearly all-male popu-
lation. Skin perfusion was not routinely assessed, and pedal
arterial flow was not scored to enable better identification
of those who would benefit from a more direct revascular-
ization.
CONCLUSIONS
The peroneal artery-only runoff is equivalent to other
vessel runoff for patency, limb salvage and wound healing
rates in patients presenting with ischemic tissue loss. Pres-
ence of gangrene and dialysis-dependence are independent
predictors of limb loss in patients presenting with tissue
mb salvage rates for groups
APP SP
mo 12 mo 24 mo 12 mo 24 mo
12% 89%  6% 89%  6% 90%  6% 90%  6%
 6% 91%  4% 88%  4% 96%  3% 91%  4%
86 .781 .477
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